Suppression of T cell immunity during sepsis
Suppression of T cell immunity during sepsis
批准号:
8237299
负责人:
Thomas S Griffith
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-10-01 至 2016-09-30
关键词:
AnimalsAntigensApoptosisApoptoticBacteriaBacterial InfectionsCD8B1 geneCause of DeathCell physiologyCellsCellular ImmunityCessation of lifeCharacteristicsComplexDataDefectDendritic CellsDevelopmentEventExperimental DesignsFailureFunctional disorderGenerationsGoalsGoldHealthcareHumanImmuneImmune System DiseasesImmune responseImmune systemImmunityImmunizationImmunosuppressionImmunosuppressive AgentsIndividualInfectionInflammatory ResponseIntensive Care UnitsIntra-abdominalKineticsLigationLinkLymphoidMaintenanceMediatingMemoryModelingMolecularMusMyelogenousMyeloid CellsNatureNosocomial InfectionsPathogenesisPatientsPeritonitisPlayPositioning AttributePredispositionProcessPuncture procedureReceptor SignalingRegulationRoleSecondary toSepsisSignal PathwayT cell responseT-LymphocyteTNF-related apoptosis-inducing ligandTherapeuticVeteransapoptosis in lymphoid cellsbaseclinically relevantcombatdesignimmune functionin vivoinnovationmortalitymouse modelnovelpreventpublic health relevanceresearch studysecondary infectionseptic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Sepsis is the leading cause of death in most intensive care units, and the death of septic patients usually does not result from the initial septic event but rather from subsequent nosocomial infections. Patients who survive severe sepsis often display severely compromised immune function. Not only is there significant apoptosis of lymphoid and myeloid cells that depletes critical components of the immune system during sepsis, there is also decreased function of the remaining immune cells. Studies in animals and humans suggest the immune defects that occur during sepsis may be critical to the pathogenesis and subsequent mortality. Using a cecal-ligation and puncture (CLP) model to induce intra-abdominal peritonitis, we recently established a mechanistic link between apoptotic cells generated during sepsis and the establishment of sepsis-induced immune suppression. We also found that the sepsis-induced immune suppression depends on generation of TNF-related apoptosis-inducing ligand (TRAIL)-expressing CD8 T cells. These results suggested TRAIL plays an important role in the induction of sepsis-induced immunosuppression, and we used this information to establish a clinically-relevant "two-hit" model of sepsis, which better reflects the delayed mortality seen during sepsis due to the second infection, to investigate sepsis-induced immune suppression of naove and memory Ag-specific CD8 T cell responses to an experimental secondary bacterial infection. Our proposed experiments will investigate the hypothesis that septic (CLP-treated) mice cannot clear a secondary infection because of the systemic suppression of the T cell compartment that is, in part, mediated by a TRAIL-dependent mechanism. Thus, the following distinct but complementary Specific Aims will be evaluated: 1 - Analyze primary CD8 T cell responses to secondary infection after sepsis and determine the role of TRAIL in sepsis- induced immunosuppression, 2 - Determine the extent to which sepsis influences the function of pre-existing memory CD8 T cells and investigate the role of TRAIL in that process, and 3 - Determine the long lasting consequences of sepsis-induced deletion of naove or memory CD8 T cells in vivo. Our experimental design will allow us to define the cellular and molecular mechanism(s) behind the induction and maintenance of sepsis-induced TRAIL-dependent suppression of T cell immunity. We also expect that the data we obtain from these studies will instrumental in the development of new TRAIL-based therapeutic approaches for counteracting the sepsis-induced immune suppression that leads to the high number of deaths seen during this uncontrolled inflammatory response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLRD Research Career Scientist Award Application
-
批准号:10582394
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:Thomas S Griffith
-
依托单位:
Integrated use of genomics, metabolomics, and cytokine profiling to validate the use of 'dirty' mice to study sepsis pathophysiology
-
批准号:10257687
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Thomas S Griffith
-
依托单位:
CD4 T cell dysfunction and reprogramming during sepsis
-
批准号:10633073
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2021
-
负责人:Thomas S Griffith
-
依托单位:
Exploiting microbial exposure to study the immune response to uropathogenic E. coli
-
批准号:10413143
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2021
-
负责人:Thomas S Griffith
-
依托单位:
Integrated use of genomics, metabolomics, and cytokine profiling to validate the use of 'dirty' mice to study sepsis pathophysiology
-
批准号:10512750
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Thomas S Griffith
-
依托单位:
Exploiting microbial exposure to study the immune response to uropathogenic E. coli
-
批准号:10237569
-
项目类别:
-
资助金额:$23.24万
-
财政年份:2021
-
负责人:Thomas S Griffith
-
依托单位:
CD4 T cell dysfunction and reprogramming during sepsis
-
批准号:10400169
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2021
-
负责人:Thomas S Griffith
-
依托单位:
Alterations in CD4 T cells during sepsis
-
批准号:9101373
-
项目类别:
-
资助金额:$31.59万
-
财政年份:2016
-
负责人:Thomas S Griffith
-
依托单位:
Impairment and recovery of CD4 T cell-dependent B cell responses after sepsis
-
批准号:10084212
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Thomas S Griffith
-
依托单位:
Suppression of T cell immunity during sepsis
-
批准号:8601255
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Thomas S Griffith
-
依托单位:
Using microbially-experienced mice to study the innate immune response in sepsis
-
批准号:10655287
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Thomas S Griffith
-
依托单位:
Using microbially-experienced mice to study the innate immune response in sepsis
-
批准号:10367761
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Thomas S Griffith
-
依托单位:
Apoptotic cells induce tolerance through TRAIL-expressing CD8+ regulatory T cells
-
批准号:7892840
-
项目类别:
-
资助金额:$37.19万
-
财政年份:2009
-
负责人:Thomas S Griffith
-
依托单位:
TRAIL: A MECHANISM FOR BCG-INDUCED ANTI-TUMOR ACTIVITY IN BLADDER CANCER
-
批准号:7604865
-
项目类别:
-
资助金额:$0.2万
-
财政年份:2007
-
负责人:Thomas S Griffith
-
依托单位:
Recombinant Immunotherapy for Renal Cell Carcinoma
-
批准号:7227055
-
项目类别:
-
资助金额:$25.8万
-
财政年份:2004
-
负责人:Thomas S Griffith
-
依托单位:
TRAIL-expressing Recombinant Adenovirus Based Immunotherapy for RCC
-
批准号:8255342
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2004
-
负责人:Thomas S Griffith
-
依托单位:
TRAIL-expressing Recombinant Adenovirus Based Immunotherapy for RCC
-
批准号:7851372
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2004
-
负责人:Thomas S Griffith
-
依托单位:
Recombinant Immunotherapy for Renal Cell Carcinoma
-
批准号:6901940
-
项目类别:
-
资助金额:$27.21万
-
财政年份:2004
-
负责人:Thomas S Griffith
-
依托单位:
Recombinant Immunotherapy for Renal Cell Carcinoma
-
批准号:6816995
-
项目类别:
-
资助金额:$27.21万
-
财政年份:2004
-
负责人:Thomas S Griffith
-
依托单位:
TRAIL-expressing Recombinant Adenovirus Based Immunotherapy for RCC
-
批准号:8484212
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2004
-
负责人:Thomas S Griffith
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: